Current through Register Vol. 51, No. 3, September 1, 2024
RELATES TO: KRS 216.510(1), 216B.042, 218A.060, 218A.180,
218A.200, 21 C.F.R. 290.10, 1306.05, 1306.11-1306.14
NECESSITY, FUNCTION, AND CONFORMITY: KRS 218A.250 requires the
Cabinet for Health and Family Services to promulgate administrative regulations
for carrying out the provisions of KRS Chapter 218A relating to controlled
substances. This administrative regulation permits the transmission of
prescriptions for Schedule II controlled substances between the prescriber and
dispenser via oral authorization for immediate administration or by facsimile
to facilitate the delivery of medications to certain patients whose need for
medication shall be initiated or changed quickly. This administrative
regulation also permits the partial filling of prescriptions for Schedule II
controlled substances if requested by the patient or prescribing practitioner
to patients whose medication needs may be long term but who wish to store
limited quantities or in situations where the pharmacy is unable to supply the
full quantity prescribed.
Section 1.
Definitions.
(1) "Hospice" means a hospice
program licensed pursuant to KRS 216B.042.
(2) "Immediate administration" means an
emergency situation in which the prescribing practitioner determines the
following criteria exists for the purposes of authorizing an oral prescription
for a Schedule II controlled substance:
(a)
Immediate administration of the controlled substance is necessary for proper
treatment of the intended ultimate user;
(b) No appropriate alternative treatment is
available, including administration of a drug that is not a Schedule II
controlled substance; and
(c) It is
not reasonably possible for the prescribing practitioner to provide a written
prescription to be presented to the person dispensing the substance prior to
the dispensing.
(3)
"Long-term care facility" or "LTCF" is defined by KRS 216.535(1)(a) and,
pursuant to KRS 218A.180(1), shall not include a family care home or personal
care home.
Section 2.
Oral Prescription Only for Immediate Administration.
(1) A pharmacist may dispense a Schedule II
controlled substance upon receiving oral authorization from a prescribing
practitioner under the following conditions:
(a) Pursuant to KRS 218A.180(1), the
prescription shall be needed for immediate administration to a patient enrolled
in a hospice program or a resident of a long-term care facility;
(b) The quantity prescribed and dispensed
shall be limited to the amount adequate to treat the patient or resident during
the period in which immediate administration is necessary; and
(c) The prescribing practitioner personally
communicates the oral prescription.
(2) Except for the signature of the
prescribing practitioner, the prescription shall:
(a) Be immediately reduced to writing by the
pharmacist in accordance with KRS 218A.180(6); and
(b) Contain all information required by KRS 218A.180(5) and 21 C.F.R. 1306.05.
(3) If the prescribing practitioner is not
known to the pharmacist, the pharmacist shall make a reasonable effort to
determine that the oral authorization came from a registered practitioner,
which may include:
(a) A callback to the
prescribing practitioner using the practitioner's phone number as listed in the
telephone directory; or
(b) Other
good faith efforts to ensure the practitioner's identity.
(4) Within seven (7) days after authorizing
an oral prescription for immediate administration, the prescribing practitioner
shall cause a written prescription for the emergency quantity prescribed to be
delivered to the dispensing pharmacist and demonstrate compliance with the
requirements established in this subsection.
(a) In addition to conforming to the
requirements of KRS 218A.180(5) and 21 C.F.R. 1306.05, the prescription shall:
1. Have written on its face "Authorization
for Emergency Dispensing" and the date of the oral order; and
2. Be delivered to the pharmacist:
a. In person;
b. By mail; or
c. Electronically pursuant to paragraph (d)
of this subsection.
(b) If delivered by mail, the prescription
shall be postmarked within seven (7) days of the date of the oral prescription
for immediate administration.
(c)
Upon receipt, the dispensing pharmacist shall attach the paper prescription to
the oral prescription for immediate administration that was earlier reduced to
writing.
(d) For electronic
prescriptions, the pharmacist shall annotate the record of the prescription
with the:
1. Original authorization;
and
2. Date of the oral
order.
(e) If the
prescribing practitioner fails to deliver a written prescription to the
pharmacist in accordance with this subsection, the pharmacist shall notify the
nearest Drug Enforcement Administration (DEA) office.
(f) Failure of the pharmacist to comply with
paragraph (e) of this subsection shall void the authority conferred by this
subsection to dispense without a written prescription of a prescribing
practitioner.
(5) A
central fill pharmacy shall not be authorized under subsection (4) of this
section to prepare prescriptions for a Schedule II controlled substance upon
receiving an oral authorization from a retail pharmacist or a prescribing
practitioner.
(6) Dispensing a
Schedule II controlled substance beyond the period necessary for immediate
administration shall be pursuant to a written prescription signed by the
prescribing practitioner.
Section
3. Transmission by Facsimile of a Prescription for a Schedule II
Controlled Substance.
(1) A prescription
prepared in accordance with KRS 218A.180, 21 C.F.R. 1306.05, 902 KAR 55:080,
and 902 KAR 55:105, Section 2, for a Schedule II narcotic substance to be
compounded for the direct administration to a patient by parenteral,
intravenous, intramuscular, subcutaneous, or intraspinal infusion may be
transmitted by a practitioner or the practitioner's agent to the dispensing
pharmacy by facsimile.
(2) A
prescription prepared in accordance with KRS 218A.180, 21 C.F.R. 1306.05, 902 KAR 55:080, and 902 KAR 55:105, Section 2, for a Schedule II controlled
substance for a resident of a long-term care facility may be transmitted by a
practitioner or the practitioner's agent to the dispensing pharmacy by
facsimile.
(3)
(a) A prescription prepared in accordance
with KRS 218A.180, 21 C.F.R. 1306.05, 902 KAR 55:080, and 902 KAR 55:105,
Section 2, for a Schedule II controlled substance for a hospice patient may be
transmitted by a practitioner or the practitioner's agent to the dispensing
pharmacy by facsimile.
(b) The
practitioner or the practitioner's agent shall note on the prescription that
the patient is a hospice patient.
(4) The facsimile prescription shall:
(a) Serve as the original written
prescription for the purposes of subsections (1) to (3) of this section and as
allowed by KRS 218A.180(1) for the dispensing of a Schedule II controlled
substance; and
(b) Be maintained in
the same manner as an original prescription.
Section 4. Partial Filling of a Prescription
for a Schedule II Controlled Substance.
(1)
Except as provided in subsections (2) and (3) of this section, a pharmacist may
partially fill a prescription for a controlled substance listed in Schedule II
if the pharmacist:
(a) Is unable to dispense
the full quantity called for in a written prescription or oral prescription for
immediate administration as authorized by Section 2 of this administrative
regulation;
(b) Makes a notation of
the quantity dispensed:
1. On the face of the
written prescription;
2. In the
written record of the oral prescription for immediate administration;
or
3. In the electronic
prescription record; and
(c) Dispenses the remaining portion of the
prescription within seventy-two (72) hours of the first partial filling. If the
remaining portion is not or cannot be filled within the seventy-two (72) hour
period, the pharmacist shall notify the prescribing practitioner. No further
quantity shall be dispensed without a new written prescription.
(2) A prescription for a Schedule
II controlled substance written for a patient in a long-term care facility or
for a patient with a documented terminal illness may be dispensed in partial
quantities, including individual dosage units, if:
(a) The pharmacist records on the
prescription whether the patient is "terminally ill" or an "LTCF
patient";
(b) The pharmacist
records on the back of the written prescription or on another appropriate
record, uniformly maintained and readily retrievable, the following data:
1. The date of the partial
dispensing;
2. The quantity
dispensed;
3. The remaining
quantity authorized to be dispensed; and
4. The identification of the dispensing
pharmacist;
(c) The
pharmacist contacts the practitioner prior to dispensing the partial quantity
if there is any question whether the patient is terminally ill because both the
pharmacist and the prescribing practitioner have a corresponding responsibility
to assure that the controlled substance is for a terminally ill
patient;
(d) The total quantity
dispensed in all partial dispensings does not exceed the quantity
prescribed;
(e) The partial
dispensing occurs at the pharmacy where the original prescription is on file;
and
(f) No dispensing occurs beyond
sixty (60) days from date of issuance of the prescription.
(3) For a patient who is not terminally ill
or a resident of a long-term care facility, a written prescription for a
Schedule II controlled substance may be dispensed in partial quantities in
accordance with the requirements established in this subsection.
(a) The partial dispensing shall be requested
by the patient or the prescribing practitioner who issued the
prescription.
(b) Dispensing shall
not occur beyond thirty (30) days from the date of issuance of the
prescription.
(c) The pharmacist
shall comply with requirements established in subsection (2)(b), (d), and (e)
of this section.
(4) The
information required by this section pertaining to current Schedule II
prescriptions may be maintained in a computerized system if the system has the
capability to permit:
(a) Output (display or
printout) of the:
1. Original prescription
number;
2. Date of issue;
3. Identification of the prescribing
practitioner;
4. Identification of
the patient;
5. Address of the
long-term care facility, hospital, or residence of the patient, if
applicable;
6. Identification of
medication authorized, including:
a.
Dosage;
b. Form;
c. Strength; and
d. Quantity;
7. Listing of the partial fillings that have
been dispensed under each prescription; and
8. Information required in 21 C.F.R. 1306.13(b);
(b) Immediate
(real time) updating of the prescription record each time a partial filling of
the prescription is conducted; and
(c) Retrieval of partially filled Schedule II
prescription information that is the same as required by KRS 218A.180(7) for
Schedule III and IV prescription refill information.
(5) If a record keeping system is being used
that does not permit refills of Schedule II controlled substances, a new
prescription number for the partial dispensing shall be permitted.
(6) A prescription that is partially filled
and does not comply with the requirements of this section shall be deemed to
have been filled in violation of KRS 218A.200(3), (4) and 21 C.F.R. 1306.13.
STATUTORY AUTHORITY: KRS 194A.050, 218A.180(1),
218A.250